These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 35489124

  • 21. High incidence of MGMT and RARbeta promoter methylation in primary glioblastomas: association with histopathological characteristics, inflammatory mediators and clinical outcome.
    Piperi C, Themistocleous MS, Papavassiliou GA, Farmaki E, Levidou G, Korkolopoulou P, Adamopoulos C, Papavassiliou AG.
    Mol Med; 2010; 16(1-2):1-9. PubMed ID: 19809523
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Aberrant DNA methylation of some tumor suppressor genes in lung cancers from workers with chromate exposure.
    Ali AH, Kondo K, Namura T, Senba Y, Takizawa H, Nakagawa Y, Toba H, Kenzaki K, Sakiyama S, Tangoku A.
    Mol Carcinog; 2011 Feb; 50(2):89-99. PubMed ID: 21229606
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Aberrant methylation of different DNA repair genes demonstrates distinct prognostic value for esophageal cancer.
    Ling ZQ, Li P, Ge MH, Hu FJ, Fang XH, Dong ZM, Mao WM.
    Dig Dis Sci; 2011 Oct; 56(10):2992-3004. PubMed ID: 21674174
    [Abstract] [Full Text] [Related]

  • 28. Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer.
    Barault L, Amatu A, Bleeker FE, Moutinho C, Falcomatà C, Fiano V, Cassingena A, Siravegna G, Milione M, Cassoni P, De Braud F, Rudà R, Soffietti R, Venesio T, Bardelli A, Wesseling P, de Witt Hamer P, Pietrantonio F, Siena S, Esteller M, Sartore-Bianchi A, Di Nicolantonio F.
    Ann Oncol; 2015 Sep; 26(9):1994-1999. PubMed ID: 26113646
    [Abstract] [Full Text] [Related]

  • 29. Clinical correlation of MGMT protein expression and promoter methylation in Chinese glioblastoma patients.
    Tang K, Jin Q, Yan W, Zhang W, You G, Liu Y, Jiang T.
    Med Oncol; 2012 Jun; 29(2):1292-6. PubMed ID: 21394635
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. MGMT promoter methylation determined by HRM in comparison to MSP and pyrosequencing for predicting high-grade glioma response.
    Switzeny OJ, Christmann M, Renovanz M, Giese A, Sommer C, Kaina B.
    Clin Epigenetics; 2016 Jun; 8():49. PubMed ID: 27158275
    [Abstract] [Full Text] [Related]

  • 32. Genetic and epigenetic alterations of the EGFR and mutually independent association with BRCA1, MGMT, and RASSF1A methylations in Vietnamese lung adenocarcinomas.
    Nguyen QN, Vuong LD, Truong VL, Ta TV, Nguyen NT, Nguyen HP, Chu HH.
    Pathol Res Pract; 2019 May; 215(5):885-892. PubMed ID: 30723053
    [Abstract] [Full Text] [Related]

  • 33. MGMT gene promoter methylation in humoral tissue as biomarker for lung cancer diagnosis: An update meta-analysis.
    Chen B, Ying X, Bao L.
    Thorac Cancer; 2021 Dec; 12(23):3194-3200. PubMed ID: 34651448
    [Abstract] [Full Text] [Related]

  • 34. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP, Zhang B, Zhang XQ, Chen M, Cao J, Liu WJ.
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
    Lee ES, Issa JP, Roberts DB, Williams MD, Weber RS, Kies MS, El-Naggar AK.
    Clin Cancer Res; 2008 May 01; 14(9):2664-72. PubMed ID: 18451230
    [Abstract] [Full Text] [Related]

  • 38. Circulating ctDNA methylation quantification of two DNA methyl transferases in papillary thyroid carcinoma.
    Khatami F, Teimoori-Toolabi L, Heshmat R, Nasiri S, Saffar H, Mohammadamoli M, Aghdam MH, Larijani B, Tavangar SM.
    J Cell Biochem; 2019 Oct 01; 120(10):17422-17437. PubMed ID: 31127647
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The TERT promoter mutation status and MGMT promoter methylation status, combined with dichotomized MRI-derived and clinical features, predict adult primary glioblastoma survival.
    Shu C, Wang Q, Yan X, Wang J.
    Cancer Med; 2018 Aug 01; 7(8):3704-3712. PubMed ID: 29984907
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.